Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
63,000
Employees63,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
63,000
Employees63,000

DHR Key Statistics

Market cap
166.71B
Market cap166.71B
Price-Earnings ratio
48.57
Price-Earnings ratio48.57
Dividend yield
0.54%
Dividend yield0.54%
Average volume
3.13M
Average volume3.13M
High today
$240.42
High today$240.42
Low today
$235.75
Low today$235.75
Open price
$238.84
Open price$238.84
Volume
3.89M
Volume3.89M
52 Week high
$258.23
52 Week high$258.23
52 Week low
$171.00
52 Week low$171.00

Stock Snapshot

Danaher(DHR) stock is priced at $235.99, giving the company a market capitalization of 166.71B. It carries a P/E multiple of 48.57 and pays a dividend yield of 54.2%.

During the trading session on 2026-01-18, Danaher(DHR) shares reached a daily high of $240.42 and a low of $235.75. At a current price of $235.99, the stock is +0.1% higher than the low and still -1.8% under the high.

Trading volume for Danaher(DHR) stock has reached 3.89M, versus its average volume of 3.13M.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $258.23 and a low of $171.00.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $258.23 and a low of $171.00.

DHR News

Simply Wall St 4d
Assessing Danaher Valuation After Upbeat Q4 2025 Guidance And Conference Preview

Advertisement Conference guidance puts Q4 and 2025 in sharper focus Danaher (DHR) updated its fourth quarter 2025 outlook ahead of the J.P. Morgan Healthcare...

Assessing Danaher Valuation After Upbeat Q4 2025 Guidance And Conference Preview
TipRanks 4d
Danaher price target raised to $265 from $255 at Argus

Argus raised the firm’s price target on Danaher (DHR) to $265 from $255 and keeps a Buy rating on the shares. Danaher is well positioned for growth, the analyst...

Nasdaq 6d
How To YieldBoost Danaher To 4.5% Using Options

Shareholders of Danaher Corp (Symbol: DHR) looking to boost their income beyond the stock's 0.5% annualized dividend yield can sell the January 2028 covered cal...

How To YieldBoost Danaher To 4.5% Using Options

Analyst ratings

86%

of 29 ratings
Buy
86.2%
Hold
13.8%
Sell
0%

More DHR News

Simply Wall St 6d
What Danaher's Stronger Q4 2025 Revenue Outlook Means For Shareholders

Danaher recently announced at the J.P. Morgan Healthcare Conference that it expects fourth-quarter 2025 revenues to grow in the mid-single digit percent range y...

What Danaher's Stronger Q4 2025 Revenue Outlook Means For Shareholders

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .